Cholesterol-Lowering Drug Lowers Risk of Diabetic Retinopathy Surgery

Dec 22, 2007

Researchers have found that fenofibrate, also known as Lofibra and TriCor, reduces the progression of diabetic retinopathy in humans. (Retinopathy occurs when the small blood vessels that supply the eye begin to leak and swell, resulting in progressive vision loss.)

To arrive at their findings, the researchers studied 9,795 type 2s between the ages of 50 and 75, half of whom received fenofibrate and the rest of whom received a placebo. After five years of follow-up, there was a 31 percent reduction in need for laser therapy to treat diabetic retinopathy in the fenofibrate patients. The researchers believe that fenofibrate may work its magic via an anti-inflammatory or antioxidant effect.

Like other fibrates, fenofibrate reduces bad cholesterol (LDL and VLDL), increases healthy HDL levels, and lowers triglycerides, reducing the accumulation of fat inside artery walls. Fibrates activate PPARs (peroxisome proliferator-activated receptors), which cause transcription of genes that help lipid metabolism. They also appear to have a beneficial effect on insulin resistance associated with the metabolic syndrome.

Interestingly, fibrates are structurally and pharmacologically related to thiazolidinediones, a class of diabetes drug that also acts on PPARs.

Sources: MedlinePlus, November 2007; Wikipedia

Click Here To View Or Post Comments

Categories: Diabetes, Diabetes, Eye Care (Retinopathy), Insulin, Type 1 Issues, Type 2 Issues

Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12th Annual Product Reference Guide
  • Insulin Syringe Chart
  • Insulin Pen Needles Chart
  • Fast-Acting Glucose
  • Sharps Disposal
  • Blood Glucose Meters Chart
  • Insulin Pumps Chart
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Top Rated
Print | Email | Share | Comments (1)

You May Also Be Interested In...


Posted by Anonymous on 28 December 2007

I wonder how it would work for Type 1 diabetics?

Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...

Username: Password:
©1991-2015 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.